Eggshell Membrane Ameliorates Hyperuricemia by Increasing Urate Excretion in Potassium Oxonate-Injected Rats

Eggshell Membrane Ameliorates Hyperuricemia by Increasing Urate Excretion in Potassium Oxonate-Injected Rats

Hyperuricemia is the primary cause of gouty arthritis and other metabolic disorders. Eggshell membrane (EM) is an effective and safe supplement for curing pain and stiffness connected with osteoarthritis. However, the effect of EM on hyperuricemia is unclear. This study determines the effects of EM...

Full description

Bibliographic Details
Main Authors:	Yoon-Young Sung, Dong-Seon Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Nutrients
Subjects:	ATP-binding cassette transporter G2 gout urate transporter 1 uric acid potassium oxonate
Online Access:	https://www.mdpi.com/2072-6643/13/10/3323

Similar Items

Emodin, a Natural Anthraquinone, Increases Uric Acid Excretion in Rats with Potassium Oxonate-Induced Hyperuricemia
by: Shen-Wei Hou, et al.
Published: (2023-05-01)

The Time-Feature of Uric Acid Excretion in Hyperuricemia Mice Induced by Potassium Oxonate and Adenine
by: Shaoshi Wen, et al.
Published: (2020-07-01)

Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms
by: Xia Zhao, et al.
Published: (2021-01-01)

Advances in Urate Excretion and Urate Transporters in Hyperuricemia
by: XIN Jiadong, ZHOU Jiabao, WU Zhiyuan, ZHANG Xuming, GAO Jiandong
Published: (2023-05-01)

Evaluation of antigout activity of Phyllanthus emblica fruit extracts on potassium oxonate-induced gout rat model
by: Vaidehi N. Sarvaiya, et al.
Published: (2015-10-01)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
by: Puja Khanna, et al.
Published: (2020-10-01)

Medically Important Alterations in Transport Function and Trafficking of ABCG2
by: László Homolya
Published: (2021-03-01)

Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1
by: Dool-Ri Oh, et al.
Published: (2019-01-01)

Moderation of oxonate-induced hyperuricemia in rats via the ingestion of an ethanol-soluble fraction of a shark cartilage proteolytic digest
by: Itsuki Murota, et al.
Published: (2012-04-01)

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice
by: Lorraine Shelly, et al.
Published: (2008-04-01)

Population-specific factors associated with fractional excretion of uric acid
by: Ravi K. Narang, et al.
Published: (2019-11-01)

Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy
by: J. Chen, et al.
Published: (2021-04-01)

The Association between Serum Testosterone and Hyperuricemia in Males
by: Meng-Ko Tsai, et al.
Published: (2022-05-01)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
by: Fernando Pérez-Ruiz, et al.
Published: (2019-05-01)

A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
by: Hidekatsu Yanai, et al.
Published: (2024-03-01)

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01)

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
by: Robert Eckenstaler, et al.
Published: (2021-06-01)

Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study
by: Edoardo Cipolletta, et al.
Published: (2021-07-01)

Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice
by: Ruixia Bao, et al.
Published: (2019-12-01)

TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
by: Xin Sun, et al.
Published: (2023-11-01)

Tubular Handling of Uric Acid and Factors Influencing Its Renal Excretion: A Short Review
by: Tubular Handling of Uric Acid and Factors Influencing Its Renal Excretion: A Short Review, et al.
Published: (2016-07-01)

Functional Characterization of Rare Variants in OAT1/<i>SLC22A6</i> and OAT3/<i>SLC22A8</i> Urate Transporters Identified in a Gout and Hyperuricemia Cohort
by: Jiří Vávra, et al.
Published: (2022-03-01)

ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL
by: Ashley M. Vaughan, et al.
Published: (2006-11-01)

Konjac glucomannan improves hyperuricemia through regulating xanthine oxidase, adenosine deaminase and urate transporters in rats
by: Yuan Zhang, et al.
Published: (2018-09-01)

Why Does Hyperuricemia Not Necessarily Induce Gout?
by: Wei-Zheng Zhang
Published: (2021-02-01)

Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1/ERK/MMP-9 signaling pathway
by: Jen-Chun Wang, et al.
Published: (2023-01-01)

Pu-erh ripened tea resists to hyperuricemia through xanthine oxidase and renal urate transporters in hyperuricemic mice
by: Ran Zhao, et al.
Published: (2017-02-01)

Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner
by: Sumiko Abe-Dohmae, et al.
Published: (2006-07-01)

Whey protein peptides PEW and LLW synergistically ameliorate hyperuricemia and modulate gut microbiota in potassium oxonate and hypoxanthine-induced hyperuricemic rats
by: Xiaofen Qi, et al.
Published: (2023-11-01)

Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01)

The Role of Bay Leaf Extract in Reducing Liver Inflammation in Mice (Mus Musculus) Induced by Potassium Oxonate
by: Evy Silvia Awwalia, et al.
Published: (2024-02-01)

Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats
by: Fei Yang, et al.
Published: (2019-05-01)

The ABC transporters of human physiology and disease : genetics and biochemistry of ATP binding cassette transporters /
by: Linton, Kenneth J., et al.
Published: (2011)

Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7
by: Michi Hayashi, et al.
Published: (2005-08-01)

Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
by: Liqing Yu, et al.
Published: (2005-08-01)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
by: Dalbeth Nicola, et al.
Published: (2012-09-01)

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
by: Ravi K. Narang, et al.
Published: (2019-01-01)

Identification of three distinct cell populations for urate excretion in human kidneys
by: Yoshihiko M. Sakaguchi, et al.
Published: (2024-01-01)

A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice
by: Yanjie Ma, et al.
Published: (2017-10-01)